SUDA Pharmaceuticals

SUDA Pharmaceuticals Ltd (SUDA), based in Australia and the US, is a world leader in reformulating and delivering medication through the oral mucosa.

Patients typically take medication as pills, tablets or capsules yet less than 25% of the medication is absorbed into the bloodstream.

SUDA can increase the bioavailability of administered medications, which means it increases the amount of the drug absorbed by the body so is able to increase the effect of that drug.

SUDA has increased bioavailability up to 95%. This is a major step forward in the evolution of drug delivery technology.

Latest Media Releases

SUDA Pharmaceuticals Placement Raises $3.65m

22/06/2021 10:10:00

SUDA Pharmaceuticals Ltd (ASX: SUD) is pleased to announce that the Company has received firm commitments for a capital raising by placing up to 96,163,997 ordinary shares to institutional and sophi…

Latest News